微泡

微泡（英語：Micro bubbles）又稱微氣泡，是氣泡直徑小於1毫米（mm），但大於一微米（μm）的水中氣泡。當把水與空氣交互衝擊，水裏會增加大量空氣泡，在一定條件下，會產生直徑小於1毫米（mm），但大於一微米（μm）的氣泡，數量夠多時甚至會令蒸餾水的顏色化成乳白色。其特性廣泛應用使用在工業、生命科學和醫學中。氣泡殼和其填充物質的組成決定了微氣泡的特徵，例如：浮力、抗壓強度、熱導率和聲學特性。 微氣泡在醫學診斷中用作超聲波成像的對比劑[1]。充滿空氣或是碳氟化合物的微泡，在應用於聲能場時振盪和振動，並可能反射超聲波。這將微泡與周圍組織區分開來。實際上，由於液體中的氣泡缺乏穩定性，因此很快就會溶解，而微氣泡必須用固體外殼包裹起來。該殼由脂質或蛋白質製成，例如由血清白蛋白殼所包裹的八氟丙烷氣體組成的微氣泡。具有與血液互相影響的親水性外層和容納氣體分子的疏水性內層在熱力學上是最穩定的。空氣、六氟化硫和碳氟化合物氣體都可以作為微氣泡內部的成分。為了新增血液中的穩定性和持久性，高分子量氣體和在血液中的低溶解度氣體是微氣泡氣核最有吸引力的候選氣體[2]。 微氣泡可用於藥物輸送[3]、生物薄膜去除[4]、膜清洗[5][6]、生物薄膜控制和水及廢水處理等目的[7]，也由船體在水中的運動產生，形成氣泡層；這可能會干擾聲納的使用，因為聲納層需要吸收或反射聲波[8]。 超聲波成像中的對比度仰賴於包含超聲波速度和組織密度函數[9]的聲阻抗及組織或感興趣區域之間[2]的差异。由於超聲波所引起的聲波與組織介面相互影響，一些聲波被反射回換能器。差值越大，反射的波越多，訊號雜訊比就越高。因此，數量級比周圍組織和血液低且更容易壓縮周圍組織和血液的微氣泡核心，在成像中提供了高對比[2]。 2.1物理反應 當暴露於超聲波時，微氣泡以兩種方式之一響應入射的壓力波而振盪。壓力越低、頻率越高、微氣泡的直徑越大，微氣泡振盪或空化就會越穩定[2]。這會導致周圍血管系統和組織附近產生音波流，產生剪應力，從而在內皮層上產生孔隙[10]。這種孔隙形成會增强內吞作用和滲透性[10]。頻率越低，壓力越高，微氣泡直徑越小，微氣泡振盪就越慣性；它們劇烈膨脹和收縮，最終導致微泡塌陷[11]。這種現象會在血管壁上產生機械應力和微射流，這已被證明會破壞緊密的細胞連接並誘導細胞滲透性[10]。極高的壓力會導致小血管破壞，但是壓力可以調節到只在體內產生短暫的孔[2][11]。微氣泡破壞對藥物傳輸載體是一個理想方法。破壞產生的力可以使微泡上的治療有效載荷移位，同時使周圍細胞對藥物的吸收敏感。 2.2藥品傳輸 微氣泡可以用多種方法作為藥物傳輸載體。其中最顯著的包括：（1）將親脂性藥物併入脂質單層，（2）將奈米顆粒和脂質體附著到微泡表面，（3）將微泡包裹在較大的脂質體內，以及（4）將核酸靜電鍵合到微氣泡表面[2][12][13][14]。 2.2.1親脂性藥物 微氣泡可通過將這些藥物併入微氣泡脂質殼來促進疏水性藥物的局部標靶[15][16][17][18][19][20][21][22]。這種封裝技術降低了全身性毒性，新增了藥物定位，並提高了疏水性藥物的溶解性[16]。對於新增的定位，標靶配體可以附加到微氣泡的外部[17][18][20][21][22]。這提高了治療效果[18]。脂質包裹的微氣泡作為藥品傳輸載體的一個缺點是其有效載荷低。為了解决這個問題，可以在脂質單層的內部加入一個油殼來提高有效載荷的效率 2.2.2奈米微粒和脂質體附著 為了增加微氣泡的有效載荷，人們開始探索脂質體[24][25][26][27]或奈米微粒 [10][28][29][30][31]附著在脂質微氣泡的外部。超音波破壞微氣泡後，這些小顆粒可以滲出到腫瘤組織中。此外，通過將這些顆粒附著在微氣泡上而不是聯合注射，藥物被限制在血流中，而不是聚集在健康組織。這種治療被降級到超音波治療的位置[26]。這種微氣泡的改版對一種脂質體劑已經在臨床上使用的阿黴素特別有吸引力[26]。對微氣泡破壞引起奈米微粒浸潤的分析表明，更高的壓力對於血管滲透性是必要的，並且可能通過促進局部液體運動和增强內吞作用來改善治療[10]。 2.2.3脂質體內負載微氣泡 另一種新的聲學反應靈敏的微氣泡系統是直接將微氣泡封裝在脂質體中。這些系統在體內的迴圈時間比單用微氣泡要長，因為這種包裝方法可以防止微氣泡溶解在血液中[32]。親水性藥物存留在脂質體內部的水介質中，而疏水性藥物聚集在脂質雙層中[32][33]。體外實驗顯示巨噬細胞不會吞噬這些顆粒[33]。 2.2.4透過靜電相互作用進行基因傳遞 微氣泡也透過帶正電荷的微氣泡外殼和帶負電荷的核酸之間的靜電鍵作為基因轉染的非病毒載體。微氣泡崩塌形成的短暫孔隙允許遺傳物質以一種比當前治療方法更安全和更具體的管道進入靶細胞[34]。微氣泡已被用於傳遞小分子核糖核酸[35][36]，質體[37]，小分子干擾核糖核酸[38]，和信使核糖核酸[39][40]。 (1)由於微氣泡體積大，不易外滲，因此其作用僅限於血管系統。奈米液滴和全氟碳化合物液滴周圍的脂質殼因為超音波脈衝而蒸發，提供了一個小直徑來促進外滲，也提供微氣泡一個的替代方案。 (2)微氣泡的半衰期很短，約為循環的幾分鐘，因此限制了治療時間。 (3)微氣泡由肝臟和脾臟過濾，如果微氣泡還沒有釋放出它們的貨物，任何藥物複合體也可能對這些器官構成毒性威脅。 (4)藥物複合體對微氣泡來說很難解釋，且這些製劑很難大量製造以廣泛使用。 (5)當微泡被用來破壞腦血管障壁時，腦組織會有少量出血，儘管這被認為是可逆的。 用於藥品傳輸的微氣泡不僅可以作為藥物載體，還可以作為一種滲透其他不可穿透的屏障（特別是血腦）及改變腫瘤微環境的方式。 2.3.1血腦屏障破壞 大腦由毛細管內的內皮細胞壁緊密連接而被保護，此稱為血腦屏障（BBB）[41]。血腦屏障嚴格調節血液進入大腦的物質，雖然這功能對健康的人來說是非常理想的，但對治療人員進入癌症患者的大腦構成了障礙。20世紀中期，超音波被顯示能破壞血腦屏障[42]，而在2000年代初期，微氣泡被證明有助於暫時的滲透[43]。此後，超音波和微氣泡治療被用於向大腦輸送的治療藥物。由於血腦屏障破裂的超音波及微氣泡治療已證明是一種安全且有前景的臨床治療，兩個臨床試驗正在檢測阿黴素[44]和卡鉑[45]與微氣泡的傳輸，以提高局部藥物濃度。 2.3.2免疫治療 除了滲透血腦屏障外，超音波和微氣泡治療還可以改變腫瘤環境，並作為免疫治療手段[46]。高強度聚焦超聲（HIFU）單獨觸發免疫反應，推測是通過促進腫瘤抗原的釋放，以獲得免疫細胞識別，活化抗原呈現細胞，促進其浸潤，抑制腫瘤免疫抑制，促進Th1輔助細胞反應[47][48]。通常，高強度聚焦超聲用於腫瘤的熱消融。低强度聚焦超聲（LIFU）結合微氣泡也顯示出可刺激免疫刺激作用，抑制腫瘤生長，新增內生性白血球浸潤[47][49]。此外，降低高強度聚焦超聲所需的聲學功率，可為患者提供更安全的治療並縮短治療時間[50]。儘管此治療有潜力，但據推測，一個完整的治療需要組合治療。超音波和微氣泡治療不需要額外藥物，阻礙了小腫瘤的生長，但需要聯合藥物治療來影響中等腫瘤的生長[51]。由於其免疫刺激機制，超音波和微氣泡提供了一種獨特的能力，可以促進或加強免疫治療，以獲得更有效的癌症治療。 [1] Blomley, Martin J K; Cooke, Jennifer C; Unger, Evan C; Monaghan, Mark J; Cosgrove, David O (2001). "Science, medicine, and the future: Microbubble contrast agents: A new era in ultrasound". BMJ. 322 (7296): 1222–5. doi:10.1136/bmj.322.7296.1222. PMC 1120332. PMID 11358777. [2] Martin, K. Heath; Dayton, Paul A. (July 2013). "Current status and prospects for microbubbles in ultrasound theranostics: Current status and prospects for microbubbles". Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 5 (4): 329–345. doi:10.1002/wnan.1219. PMC 3822900. PMID 23504911. [3] Sirsi, Shashank; Borden, Mark (2009). "Microbubble compositions, properties and biomedical applications". Bubble Science, Engineering & Technology. 1 (1–2): 3–17. doi:10.1179/175889709X446507. PMC 2889676. PMID 20574549. [4] Mukumoto, Mio; Ohshima, Tomoko; Ozaki, Miwa; Konishi, Hirokazu; Maeda, Nobuko; Nakamura, Yoshiki (2012). "Effect of microbubbled water on the removal of a biofilm attached to orthodontic appliances — an in vitro study". Dental Materials Journal. 31 (5): 821–7. doi:10.4012/dmj.2012-091. PMID 23037846. [5] Agarwal, Ashutosh; Ng, Wun Jern; Liu, Yu (January 1, 2013). "Cleaning of biologically fouled membranes with self-collapsing microbubbles". Biofouling. 29 (1): 69–76. doi:10.1080/08927014.2012.746319. PMID 23194437. S2CID 19107010 – via Taylor and Francis+NEJM. [6] Agarwal, Ashutosh; Ng, Wun Jern; Liu, Yu, (2012). "Cleaning of biologically fouled membranes with self-collapsing microbubbles". Biofouling 29 (1): 69-76. doi:10.1080/08927014.2012.746319[permanent dead link] [7] Agarwal, Ashutosh; Ng, Wun Jern; Liu, Yu (2011). "Principle and applications of microbubble and nanobubble technology for water treatment". Chemosphere. 84 (9): 1175–80. Bibcode:2011Chmsp..84.1175A. doi:10.1016/j.chemosphere.2011.05.054. PMID 21689840. [8] Griffiths, Brian; Sabto, Michele (25 June 2012). "Quiet on board please: science underway". ECOS. [9] Cikes, Maja; D’hooge, Jan; Solomon, Scott D. (2019), "Physical Principles of Ultrasound and Generation of Images", Essential Echocardiography, Elsevier, pp. 1–15.e1, doi:10.1016/b978-0-323-39226-6.00001-1, ISBN 978-0-323-39226-6 [10] Snipstad, Sofie; Berg, Sigrid; Mørch, Ýrr; Bjørkøy, Astrid; Sulheim, Einar; Hansen, Rune; Grimstad, Ingeborg; van Wamel, Annemieke; Maaland, Astri F.; Torp, Sverre H.; Davies, Catharina de Lange (November 2017). "Ultrasound Improves the Delivery and Therapeutic Effect of Nanoparticle-Stabilized Microbubbles in Breast Cancer Xenografts". Ultrasound in Medicine & Biology. 43 (11): 2651–2669. doi:10.1016/j.ultrasmedbio.2017.06.029. PMID 28781149. [11] Hernot, Sophie; Klibanov, Alexander L. (June 2008). "Microbubbles in ultrasound-triggered drug and gene delivery". Advanced Drug Delivery Reviews. 60 (10): 1153–1166. doi:10.1016/j.addr.2008.03.005. PMC 2720159. PMID 18486268. [12] Klibanov, Alexander L. (March 2006). "Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications". Investigative Radiology. 41 (3): 354–362. doi:10.1097/01.rli.0000199292.88189.0f. ISSN 0020-9996. PMID 16481920. S2CID 27546582. [13] Ibsen, Stuart; Schutt; Esener (May 2013). "Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment". Drug Design, Development and Therapy. 7: 375–88. doi:10.2147/DDDT.S31564. ISSN 1177-8881. PMC 3650568. PMID 23667309. [14] Mullick Chowdhury, Sayan; Lee, Taehwa; Willmann, Jürgen K. (2017-07-01). "Ultrasound-guided drug delivery in cancer". Ultrasonography. 36 (3): 171–184. doi:10.14366/usg.17021. ISSN 2288-5919. PMC 5494871. PMID 28607323. [15] Tinkov, Steliyan; Coester, Conrad; Serba, Susanne; Geis, Nicolas A.; Katus, Hugo A.; Winter, Gerhard; Bekeredjian, Raffi (December 2010). "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: In-vivo characterization". Journal of Controlled Release. 148 (3): 368–372. doi:10.1016/j.jconrel.2010.09.004. PMID 20868711. [16] Ren, Shu-Ting; Liao, Yi-Ran; Kang, Xiao-Ning; Li, Yi-Ping; Zhang, Hui; Ai, Hong; Sun, Qiang; Jing, Jing; Zhao, Xing-Hua; Tan, Li-Fang; Shen, Xin-Liang (June 2013). "The Antitumor Effect of a New Docetaxel-Loaded Microbubble Combined with Low-Frequency Ultrasound In Vitro: Preparation and Parameter Analysis". Pharmaceutical Research. 30 (6): 1574–1585. doi:10.1007/s11095-013-0996-5. ISSN 0724-8741. PMID 23417512. S2CID 18668573. [17] Liu, Hongxia; Chang, Shufang; Sun, Jiangchuan; Zhu, Shenyin; Pu, Caixiu; Zhu, Yi; Wang, Zhigang; Xu, Ronald X. (2014-01-06). "Ultrasound-Mediated Destruction of LHRHa-Targeted and Paclitaxel-Loaded Lipid Microbubbles Induces Proliferation Inhibition and Apoptosis in Ovarian Cancer Cells". Molecular Pharmaceutics. 11 (1): 40–48. doi:10.1021/mp4005244. ISSN 1543-8384. PMC 3903397. PMID 24266423. [18] Pu, Caixiu; Chang, Shufang; Sun, Jiangchuan; Zhu, Shenyin; Liu, Hongxia; Zhu, Yi; Wang, Zhigang; Xu, Ronald X. (2014-01-06). "Ultrasound-Mediated Destruction of LHRHa-Targeted and Paclitaxel-Loaded Lipid Microbubbles for the Treatment of Intraperitoneal Ovarian Cancer Xenografts". Molecular Pharmaceutics. 11 (1): 49–58. doi:10.1021/mp400523h. ISSN 1543-8384. PMC 3899929. PMID 24237050. [19] Kang, Juan; Wu, Xiaoling; Wang, Zhigang; Ran, Haitao; Xu, Chuanshan; Wu, Jinfeng; Wang, Zhaoxia; Zhang, Yong (January 2010). "Antitumor Effect of Docetaxel-Loaded Lipid Microbubbles Combined With Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors". Journal of Ultrasound in Medicine. 29 (1): 61–70. doi:10.7863/jum.2010.29.1.61. PMID 20040776. S2CID 35510004. [20] Li, Yan; Huang, Wenqi; Li, Chunyan; Huang, Xiaoteng (2018). "Indocyanine green conjugated lipid microbubbles as an ultrasound-responsive drug delivery system for dual-imaging guided tumor-targeted therapy". RSC Advances. 8 (58): 33198–33207. Bibcode:2018RSCAd...833198L. doi:10.1039/C8RA03193B. ISSN 2046-2069. [21] Su, Jilian; Wang, Junmei; Luo, Jiamin; Li, Haili (August 2019). "Ultrasound-mediated destruction of vascular endothelial growth factor (VEGF) targeted and paclitaxel loaded microbubbles for inhibition of human breast cancer cell MCF-7 proliferation". Molecular and Cellular Probes. 46: 101415. doi:10.1016/j.mcp.2019.06.005. PMID 31228519. [22] Li, Tiankuan; Hu, Zhongqian; Wang, Chao; Yang, Jian; Zeng, Chuhui; Fan, Rui; Guo, Jinhe (2020). "PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation". Biomaterials Science. 8 (5): 1418–1430. doi:10.1039/C9BM01575B. ISSN 2047-4830. PMID 31942578. [23] Unger, Evan C.; McCREERY, Thomas P.; Sweitzer, Robert H.; Caldwell, Veronica E.; Wu, Yunqiu (December 1998). "Acoustically Active Lipospheres Containing Paclitaxel: A New Therapeutic Ultrasound Contrast Agent". Investigative Radiology. 33 (12): 886–892. doi:10.1097/00004424-199812000-00007. ISSN 0020-9996. PMID 9851823. [24] Escoffre, J.; Mannaris, C.; Geers, B.; Novell, A.; Lentacker, I.; Averkiou, M.; Bouakaz, A. (January 2013). "Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery". IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control. 60 (1): 78–87. doi:10.1109/TUFFC.2013.2539. ISSN 0885-3010. PMID 23287915. S2CID 5540324. [25] Deng, Zhiting; Yan, Fei; Jin, Qiaofeng; Li, Fei; Wu, Junru; Liu, Xin; Zheng, Hairong (January 2014). "Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome–microbubble complexes assisted by ultrasound". Journal of Controlled Release. 174: 109–116. doi:10.1016/j.jconrel.2013.11.018. PMID 24287101. [26] Lentacker, Ine; Geers, Bart; Demeester, Joseph; De Smedt, Stefaan C; Sanders, Niek N (January 2010). "Design and Evaluation of Doxorubicin-containing Microbubbles for Ultrasound-triggered Doxorubicin Delivery: Cytotoxicity and Mechanisms Involved". Molecular Therapy. 18 (1): 101–108. doi:10.1038/mt.2009.160. PMC 2839231. PMID 19623162. [27] Lentacker, Ine; Geers, Bart; Demeester, Jo; De Smedt, Stefaan C.; Sanders, Niek N. (November 2010). "Tumor cell killing efficiency of doxorubicin loaded microbubbles after ultrasound exposure". Journal of Controlled Release. 148 (1): e113–e114. doi:10.1016/j.jconrel.2010.07.085. PMID 21529584. [28] Gong, Yuping; Wang, Zhigang; Dong, Guifang; Sun, Yang; Wang, Xi; Rong, Yue; Li, Maoping; Wang, Dong; Ran, Haitao (2014-11-04). "Low-intensity focused ultrasound mediated localized drug delivery for liver tumors in rabbits". Drug Delivery. 23 (7): 2280–2289. doi:10.3109/10717544.2014.972528. ISSN 1071-7544. PMID 25367869. S2CID 41067520. [29] Lee; Moon; Han; Lee; Kim; Lee; Ha; Kim; Chung (2019-04-24). "Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors". Cancers. 11 (4): 581. doi:10.3390/cancers11040581. ISSN 2072-6694. PMC 6521081. PMID 31022951. [30] Ha, Shin-Woo; Hwang, Kihwan; Jin, Jun; Cho, Ae-Sin; Kim, Tae Yoon; Hwang, Sung Il; Lee, Hak Jong; Kim, Chae-Yong (2019-05-24). "Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system". International Journal of Nanomedicine. 14: 3743–3752. doi:10.2147/ijn.s193258. PMC 6539164. PMID 31213800. [31] Liufu, Chun; Li, Yue; Tu, Jiawei; Zhang, Hui; Yu, Jinsui; Wang, Yi; Huang, Pintong; Chen, Zhiyi (2019-11-15). "Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System". International Journal of Nanomedicine. 14: 8923–8941. doi:10.2147/ijn.s217338. PMC 6863126. PMID 31814720. [32] Wrenn, Steven; Dicker, Stephen; Small, Eleanor; Mleczko, Michal (September 2009). "Controlling cavitation for controlled release". 2009 IEEE International Ultrasonics Symposium. Rome: IEEE: 104–107. doi:10.1109/ULTSYM.2009.5442045. ISBN 978-1-4244-4389-5. S2CID 34883820. [33] Ibsen, Stuart; Benchimol, Michael; Simberg, Dmitri; Schutt, Carolyn; Steiner, Jason; Esener, Sadik (November 2011). "A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload". Journal of Controlled Release. 155 (3): 358–366. doi:10.1016/j.jconrel.2011.06.032. PMC 3196035. PMID 21745505. [34] Rychak, Joshua J.; Klibanov, Alexander L. (June 2014). "Nucleic acid delivery with microbubbles and ultrasound". Advanced Drug Delivery Reviews. 72: 82–93. doi:10.1016/j.addr.2014.01.009. PMC 4204336. PMID 24486388. [35] Meng, Lingwu; Yuan, Shaofei; Zhu, Linjia; ShangGuan, Zongxiao; Zhao, Renguo (2019-09-13). "Ultrasound-microbubbles-mediated microRNA-449a inhibits lung cancer cell growth via the regulation of Notch1". OncoTargets and Therapy. 12: 7437–7450. doi:10.2147/ott.s217021. PMC 6752164. PMID 31686849. [36] Wang, Xiaowei; Searle, Amy; Hohmann, Jan David; Liu, Leo; Abraham, Meike; Palasubramaniam, Jathushan; Lim, Bock; Yao, Yu; Wallert, Maria; Yu, Eefang; Chen, Yung; Peter, Karlheinz (July 2017). "Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development". Molecular Therapy. 26 (4): 1056–1065. doi:10.1016/j.ymthe.2018.02.010. PMC 6080135. PMID 29525742. [37] Cai, Junhong; Huang, Sizhe; Yi, Yuping; Bao, Shan (May 2019). "Ultrasound microbubble-mediated CRISPR/Cas9 knockout of C-erbB-2 in HEC-1A cells". Journal of International Medical Research. 47 (5): 2199–2206. doi:10.1177/0300060519840890. ISSN 0300-0605. PMC 6567764. PMID 30983484. [38] Zhao, Ranran; Liang, Xiaolong; Zhao, Bo; Chen, Min; Liu, Renfa; Sun, Sujuan; Yue, Xiuli; Wang, Shumin (August 2018). "Ultrasound assisted gene and photodynamic synergistic therapy with multifunctional FOXA1-siRNA loaded porphyrin microbubbles for enhancing therapeutic efficacy for breast cancer". Biomaterials. 173: 58–70. doi:10.1016/j.biomaterials.2018.04.054. PMID 29758547. [39] Abraham, Meike; Peter, Karlheinz; Michel, Tatjana; Wendel, Hans; Krajewski, Stefanie; Wang, Xiaowei (April 2017). "Nanoliposomes for safe and efficient therapeutic mRNA delivery: A step toward nanotheranostics in inflammatory and cardiovascular diseases as well as cancer". Nanotheranostics. 1 (2): 154–165. doi:10.7150/ntno.19449. PMC 5646717. PMID 29071184. [40] Michel, Tatjana; Luft, Daniel; Abraham, Meike; Reinhardt, Sabina; Medinal, Martha; Kurz, Julia; Schaller, Martin; Avci-Adali, Meltem; Schlensak, Christian; Peter, Karlheinz; Wendel, Hans; Wang, Xiaowei; Krajewski, Stefanie (July 2017). "Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications". Molecular Therapy Nucleic Acids. 8: 459–468. doi:10.1016/j.omtn.2017.07.013. PMC 5545769. PMID 28918045. [41] Abbott, N. Joan; Patabendige, Adjanie A.K.; Dolman, Diana E.M.; Yusof, Siti R.; Begley, David J. (January 2010). "Structure and function of the blood–brain barrier". Neurobiology of Disease. 37 (1): 13–25. doi:10.1016/j.nbd.2009.07.030. PMID 19664713. S2CID 14753395. [42] Bakay, L. (1956-11-01). "Ultrasonically Produced Changes in the Blood-Brain Barrier". Archives of Neurology and Psychiatry. 76 (5): 457–67. doi:10.1001/archneurpsyc.1956.02330290001001. ISSN 0096-6754. PMID 13371961. [43] Hynynen, Kullervo; McDannold, Nathan; Vykhodtseva, Natalia; Jolesz, Ferenc A. (September 2001). "Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits". Radiology. 220 (3): 640–646. doi:10.1148/radiol.2202001804. ISSN 0033-8419. PMID 11526261. [44] "A Study to Evaluate the Safety and Feasibility of Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound With Intravenous Ultrasound Contrast Agents in the Treatment of Brain Tumours With Doxorubicin". January 23, 2020 – via clinicaltrials.gov. [45] "A Study to Evaluate the Safety of Transient Opening of the Blood-Brain Barrier by Low Intensity Pulsed Ultrasound With the SonoCloud Implantable Device in Patients With Recurrent Glioblastoma Before Chemotherapy Administration". October 10, 2018 – via clinicaltrials.gov. [46] Escoffre, Jean-Michel; Deckers, Roel; Bos, Clemens; Moonen, Chrit (2016), Escoffre, Jean-Michel; Bouakaz, Ayache (eds.), "Bubble-Assisted Ultrasound: Application in Immunotherapy and Vaccination", Therapeutic Ultrasound, Springer International Publishing, 880, pp. 243–261, doi:10.1007/978-3-319-22536-4_14, ISBN 978-3-319-22535-7, PMID 26486342 [47] Liu, Hao-Li; Hsieh, Han-Yi; Lu, Li-An; Kang, Chiao-Wen; Wu, Ming-Fang; Lin, Chun-Yen (2012). "Low-pressure pulsed focused ultrasound with microbubbles promotes an anticancer immunological response". Journal of Translational Medicine. 10 (1): 221. doi:10.1186/1479-5876-10-221. ISSN 1479-5876. PMC 3543346. PMID 23140567. [48] Shi, Guilian; Zhong, Mingchuan; Ye, Fuli; Zhang, Xiaoming (November 2019). "Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities". Cancer Biology & Medicine. 16 (4): 714–728. doi:10.20892/j.issn.2095-3941.2019.0232 (inactive 2021-01-14). ISSN 2095-3941. PMC 6936245. PMID 31908890. [49] Sta Maria, Naomi S.; Barnes, Samuel R.; Weist, Michael R.; Colcher, David; Raubitschek, Andrew A.; Jacobs, Russell E. (2015-11-10). Mondelli, Mario U. (ed.). "Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells". PLOS ONE. 10 (11): e0142767. Bibcode:2015PLoSO..1042767S. doi:10.1371/journal.pone.0142767. ISSN 1932-6203. PMC 4640510. PMID 26556731. [50] Suzuki, Ryo; Oda, Yusuke; Omata, Daiki; Nishiie, Norihito; Koshima, Risa; Shiono, Yasuyuki; Sawaguchi, Yoshikazu; Unga, Johan; Naoi, Tomoyuki; Negishi, Yoichi; Kawakami, Shigeru (March 2016). "Tumor growth suppression by the combination of nanobubbles and ultrasound". Cancer Science. 107 (3): 217–223. doi:10.1111/cas.12867. PMC 4814255. PMID 26707839. [51] Lin, Win-Li; Lin, Chung-Yin; Tseng, Hsiao-Ching; Shiu, Heng-Ruei; Wu, Ming-Fang (April 2012). "Ultrasound sonication with microbubbles disrupts blood vessels and enhances tumor treatments of anticancer nanodrug". International Journal of Nanomedicine. 7: 2143–52. doi:10.2147/IJN.S29514. ISSN 1178-2013. PMC 3356217. PMID 22619550.